Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Injection vs Splinting for Carpal Tunnel Syndrome
NCT02539186Completed
- Sponsor
- Tri-Service General Hospital
- Start
- Aug 2015
- Primary completion
- Sep 2017
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Randomised, open-label trial of autologous platelet-rich plasma in carpal tunnel syndrome (CTS) (2 arms), sponsored by Tri-Service General Hospital. Primary endpoint: Change from baseline of pain at 24 weeks. Started Aug 2015; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT02539186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02539186.